Houston Methodist DeBakey Heart and Vascular Center
Avatar

TAVR for Stenosis: Is It for Every Patient?

By Houston Methodist DeBakey Heart and Vascular Center FEATURING Michael Reardon
June 22, 2022
2 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Boston Scientific
Cerebral Embolic Protection: Data and Limitations in the Current Era…
Fri, May 8, 2020
Faculty: Amar Krishnaswamy , Carlos Sanchez , Boston Scientific , Kendra Grubb
Teleflex
Optimizing Efficiency in TAVR: Large Bore Access Site Management
Thu, Nov 12, 2020
Faculty: Bruce Rutkin , Teleflex .
Boston Scientific
Cerebral Embolic Protection and the Low Risk TAVR Patient
Mon, Nov 1, 2021
Faculty: James Harvey , Suzanne Baron , Boston Scientific
Boston Scientific
Lifetime Management and Cerebral Embolic Protection in TAVR
Thu, Apr 14, 2022
Faculty: Boston Scientific , Thomas Waggoner , Kendra Grubb
Boston Scientific
Practical Use of SENTINEL™ Cerebral Protection System & Insights fro…
Wed, Dec 14, 2022
Faculty: Vinod Thourani , Michael Rinaldi , Boston Scientific
24:31
Vinod Thourani

How Do I Treat Low Gradient & Severe Aortic Stenosis?

15:39
Medtronic

Evolut FX TAVR Case: Cusp Overlap Technique, 26 mm valve

Feat. J. Rovin, J. Patel
16:33
Medtronic

Evolut FX TAVR Case: Cusp Overlap Technique, 34 mm valve

Feat. J. Rovin, J. Patel
62:13
Medtronic

Hot Topics, Hotter Questions

Feat. A. Almanfi, G. Fontana, S. Baron
12:45
Miami Valves

Suprasternal Direct Aortic Approach TAVR Avoid Sternotomy and Thraco…

Feat. A. Kiser
29:50
University of Miami

Catheter Based Treatment of Structural Heart Disease - Year in Review

Feat. E. De Marchena
04:27
Medtronic

Valve Durability Meta-Analysis

Feat. G. Attizzani
11:45
Medtronic

SURTAVI Five-Year Results

Feat. M. Reardon, N. Van Mieghem
12:19
Medtronic

A Closer Look: 5-Year Data from CoreValve US Pivotal and SURTAVI Tri…

Feat. M. Reardon
36:11
ARCH Advanced Revascularization Symposium

The UPSTREAM Management of Aortic Stenosis in the Future

Feat. M. Leon
70:52
Medtronic

Post-TAVR Coronary Access: Hands-on with the Heartroid

Feat. D. Talreja
17:08
JenaValve

TVT 2021 - The Future Role of TAVR in Aortic Regurgitation Therapy: …

Feat. T. Vahl, O. Ben-Yehuda, M. Mack
09:48
American College of Cardiology

PARTNER 3 Trial: Should TAVR or SAVR Be Performed Among Low-risk Pat…

Feat. D. Adams, V. Fuster, R. Mehran, A. Lala-Trindade, V. Reddy
13:53
JenaValve

TVT 2021 - Characterizing the Transcatheter Need for High-Risk Sever…

Feat. T. Vahl, V. Thourani, M. Mack, H. Treede
12:45
Scripps Health: 2019 Eighth Annual Structural Heart Intervention and Imaging

Cerebral Protection for TAVR: When and Why

Feat. D. Rizik
07:23
Medtronic .

Drs. Michael Reardon and Kendra Grubb’s Interview on the SVD Data Pr…

Feat. M. Reardon, K. Grubb
56:22
JenaValve

Aortic Regurgitation Webinar: A Disease State Review, Current Treatm…

Feat. V. Thourani, J. McCabe, M. Russo
64:51
Getinge

SCAI Scientific Sessions 2022 - MCS Support: Practical Use of IABP -…

Feat. A. Truesdell, M. Ansari
53:21
Medtronic

St. Francis Hospital & Heart Center Bicuspid Case with Post-Case…

Feat. G. Petrossian, N. Robinson, J. Popma, W. Chung
01:51
JenaValve

ALIGN-AR Call to Action - Refer Severe, Symptomatic AR Patients with…

Feat. V. Thourani